Page last updated: 2024-08-21

levonorgestrel and Ovarian Neoplasms

levonorgestrel has been researched along with Ovarian Neoplasms in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's0 (0.00)29.6817
2010's12 (75.00)24.3611
2020's3 (18.75)2.80

Authors

AuthorsStudies
Chin, JPS; Mok, ZW1
Caldwell, A; Joseph, S; Landrum, LM; Minalt, N; Peipert, JF; Robertson, SE; Yedlicka, GM1
Joy, KM1
Barra, F; Costantini, S; D'Alessandro, G; Ferrero, S; Frigerio, M; Gustavino, C1
Aarflot, M; Braaten, T; Bøvelstad, HM; Jareid, M; Lund, E; Thalabard, JC1
Amat, L; Bulach, A; Leclercq, M; Mesrine, S; Scheffler, F; Scheffler, M; Sperandeo, D1
Alberts, DS; Bartels, PH; Basil, J; Hunn, J; Hurteau, J; Kauderer, J; Lele, S; Modesitt, SC; Rodriguez, GC; Russell, S; Thaete, LG; Watkin, WG; Yozwiak, M; Zhang, HH; Zivanovic, O1
Dyba, T; Koskela-Niska, V; Lyytinen, H; Pukkala, E; Ylikorkala, O1
Grénman, S; Hurskainen, R; Mäenpää, J; Paavonen, J; Pukkala, E; Soini, T2
Cho, YJ; Jung, YW; Kim, MK; Kim, ML; Seong, SJ; Yun, BS1
Curtis, KM; Marchbanks, PA; Whiteman, MK; Zapata, LB1
Bocciolone, L; Boveri, S; Casadio, C; Franchi, D; Minig, L; Sideri, M1
Jung, YW; Kim, JW; Seong, SJ1
Cutillas, N; Espinosa, A; Hannon, MJ; Rodríguez, V; Ruiz, J1
Huggins, GR; Wentz, AC1

Reviews

4 review(s) available for levonorgestrel and Ovarian Neoplasms

ArticleYear
Association between intrauterine device use and endometrial, cervical, and ovarian cancer: an expert review.
    American journal of obstetrics and gynecology, 2023, Volume: 229, Issue:2

    Topics: Cervix Uteri; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms; Uterine Cervical Neoplasms

2023
Contraception options for patients with known hereditary risk for ovarian cancer.
    JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:11

    Topics: Adult; Contraceptives, Oral; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms; Prophylactic Surgical Procedures; Salpingectomy; Sterilization, Tubal; Young Adult

2019
Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 156, Issue:3

    Topics: Carcinoma, Ovarian Epithelial; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms

2022
Intrauterine device use among women with ovarian cancer: a systematic review.
    Contraception, 2010, Volume: 82, Issue:1

    Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms

2010

Trials

1 trial(s) available for levonorgestrel and Ovarian Neoplasms

ArticleYear
Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.
    Cancer prevention research (Philadelphia, Pa.), 2019, Volume: 12, Issue:6

    Topics: Adult; Aged; Apoptosis; Cell Proliferation; Contraceptive Agents, Hormonal; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Levonorgestrel; Middle Aged; Ovarian Neoplasms; Prognosis

2019

Other Studies

11 other study(ies) available for levonorgestrel and Ovarian Neoplasms

ArticleYear
Rare case of coexisting ovarian Brenner tumour and ovarian stromal hyperplasia presenting with persistent endometrial hyperplasia following treatment with levonorgestrel-intrauterine system.
    BMJ case reports, 2022, Dec-21, Volume: 15, Issue:12

    Topics: Brenner Tumor; Endometrial Hyperplasia; Female; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms

2022
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
    Gynecologic oncology, 2018, Volume: 149, Issue:1

    Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Neoplasms, Glandular and Epithelial; Norway; Ovarian Neoplasms; Prospective Studies; Surveys and Questionnaires

2018
[Additional non-contraceptive effects of contraception: CNGOF Contraception Guidelines].
    Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:12

    Topics: Administration, Cutaneous; Administration, Intravaginal; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Ovarian Cysts; Ovarian Neoplasms; Pregnancy

2018
Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
    International journal of cancer, 2013, Oct-01, Volume: 133, Issue:7

    Topics: Aged; Aged, 80 and over; Case-Control Studies; Contraceptive Agents, Female; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Finland; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Registries; Risk

2013
Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.
    Obstetrics and gynecology, 2014, Volume: 124, Issue:2 Pt 1

    Topics: Adenocarcinoma; Adult; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Finland; Follow-Up Studies; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Lung Neoplasms; Menorrhagia; Middle Aged; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Registries

2014
Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:11

    Topics: Adult; Cohort Studies; Contraceptive Agents, Female; Fallopian Tube Neoplasms; Female; Finland; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Ovarian Neoplasms; Risk Factors

2016
The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016, Volume: 134, Issue:3

    Topics: Adult; Combined Modality Therapy; Contraceptives, Oral, Combined; Drug Administration Schedule; Endometriosis; Female; Humans; Levonorgestrel; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Republic of Korea; Retrospective Studies; Treatment Outcome; Young Adult

2016
Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3

    Topics: Adult; Antineoplastic Agents, Hormonal; Drug Delivery Systems; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Ovarian Neoplasms; Pregnancy; Prospective Studies; Recurrence; Treatment Outcome; Young Adult

2011
Should diagnostic laparoscopy be conducted before hormonal treatment in early-stage endometrial cancer?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3

    Topics: Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Drug Therapy, Combination; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Levonorgestrel; Neoplasms, Multiple Primary; Ovarian Neoplasms

2011
A potent ruthenium(II) antitumor complex bearing a lipophilic levonorgestrel group.
    Inorganic chemistry, 2011, Sep-19, Volume: 50, Issue:18

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Female; Guanine; Humans; Levonorgestrel; Models, Molecular; Ovarian Neoplasms; Ruthenium

2011
Obstetrics and gynecology.
    JAMA, 1993, Jul-14, Volume: 270, Issue:2

    Topics: Female; Gynecology; Humans; Infertility; Levonorgestrel; Medroxyprogesterone Acetate; Obstetrics; Ovarian Neoplasms; United States

1993